Cargando…

Para-Aminosalicylic Acid: Pas

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1950
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191301/ https://www.ncbi.nlm.nih.gov/pubmed/15428058

Ejemplares similares

p-Aminosalicylic Acid (P.A.S.)
por: Spring, F. S.
Publicado: (1949)

Endometrial Tuberculosis Treated with Para-Aminosalicylic Acid (PAS): Report of a Case with Subsequent Pregnancy
por: Kullander, Stig
Publicado: (1952)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains
por: Wei, Wenjing, et al.
Publicado: (2019)

Clinical Study of the Use of Para-Aminosalicylic Acid in the Treatment of Pulmonary Tuberculosis
por: Donaldson, Rose I. L.
Publicado: (1949)

Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis
por: Pandey, Bharati, et al.
Publicado: (2019)

para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
por: Zheng, Jun, et al.
Publicado: (2013)

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019)

A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis
por: Heo, Jinyeong, et al.
Publicado: (2022)

Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China
por: Luo, Ming, et al.
Publicado: (2019)

Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to para-Aminosalicylic Acid in Mycobacterium tuberculosis
por: Yu, Ji-fang, et al.
Publicado: (2022)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
por: Perrotta, Cristiana, et al.
Publicado: (2015)

Methionine Antagonizes para-Aminosalicylic Acid Activity via Affecting Folate Precursor Biosynthesis in Mycobacterium tuberculosis
por: Howe, Michael D., et al.
Publicado: (2018)

Utility of para-aminosalicylic acid in drug-resistant tuberculosis: Should it be classified as Group D3 or Group C?
por: Desai, Unnati, et al.
Publicado: (2018)

dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains
por: Moradigaravand, Danesh, et al.
Publicado: (2016)

Development of a Highly Biocompatible Antituberculosis Nanodelivery Formulation Based on Para-Aminosalicylic Acid—Zinc Layered Hydroxide Nanocomposites
por: Saifullah, Bullo, et al.
Publicado: (2014)

Protective Effects of Sodium Para-Aminosalicylic Acid on Lead and Cadmium Co-Exposure in SH-SY5Y Cells
por: Peng, Jian-Chao, et al.
Publicado: (2023)

Aminosalicylates and COVID-19: Facts or Coincidences?
por: Magro, Fernando, et al.
Publicado: (2021)

Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid
por: Shrivastava, P. K., et al.
Publicado: (2013)

The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
por: Rousseaux, Christel, et al.
Publicado: (2013)

Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps
por: Kirchner, Tina, et al.
Publicado: (2013)

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
por: Broekman, Mark M. T. J., et al.
Publicado: (2015)

The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats
por: Banaei, Shokofeh
Publicado: (2016)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid–Sulfamethazine Cocrystals
por: Salem, Ala’, et al.
Publicado: (2021)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

Antimycobacterial, antimicrobial, and biocompatibility properties of para-aminosalicylic acid with zinc layered hydroxide and Zn/Al layered double hydroxide nanocomposites
por: Saifullah, Bullo, et al.
Publicado: (2014)

Self-Assembling Polymers with p-Aminosalicylate Anions Supported by Encapsulation of p-Aminosalicylate for the Improvement of Drug Content and Release Efficiency
por: Keihankhadiv, Shadi, et al.
Publicado: (2023)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
por: Sener, Aziz, et al.
Publicado: (2018)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019)

De battre le cœur ne doit pas s’arrêter
por: Badoual, Cécile
Publicado: (2021)

Test des moteurs pas à pas
por: Daneels, A, et al.
Publicado: (1976)

A Novel Preparation Method for 5-Aminosalicylic Acid Loaded Eudragit S100 Nanoparticles
por: Hu, Daode, et al.
Publicado: (2012)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
por: Lee, Jin, et al.
Publicado: (2019)

Aminosalicylic acid reduces ER stress and Schwann cell death induced by MPZ mutations
por: Chang, Eun Hyuk, et al.
Publicado: (2019)

Controlled Release of 5-Aminosalicylic Acid (5-ASA) from New Biodegradable Polyurethanes
por: Kenawy, El-Refaie, et al.
Publicado: (2010)

Topical Aminosalicylic Acid Improves Keratinocyte Differentiation in an Inducible Mouse Model of Harlequin Ichthyosis
por: Cottle, Denny L., et al.
Publicado: (2020)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cc54gkgnvg693m3cub4tjp002j